CHRDL2 Antikörper (AA 351-429) (AbBy Fluor® 750)
-
- Target Alle CHRDL2 Antikörper anzeigen
- CHRDL2 (Chordin-Like 2 (CHRDL2))
-
Bindungsspezifität
- AA 351-429
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHRDL2 Antikörper ist konjugiert mit AbBy Fluor® 750
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus, Ratte
- Homologie
- Human,Cow,Sheep
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CHRDL2
- Isotyp
- IgG
- Top Product
- Discover our top product CHRDL2 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- CHRDL2 (Chordin-Like 2 (CHRDL2))
- Andere Bezeichnung
- CHRDL2 (CHRDL2 Produkte)
- Synonyme
- BNF1 antikoerper, CHL2 antikoerper, FKSG37 antikoerper, 1810022C01Rik antikoerper, Chl2 antikoerper, chl antikoerper, si:dkey-11j5.7 antikoerper, si:dkey-11j5.7-like antikoerper, chordin like 2 antikoerper, chordin-like 2 antikoerper, CHRDL2 antikoerper, Chrdl2 antikoerper, chrdl2 antikoerper
- Hintergrund
-
Synonyms: BNF1, Breast tumor novel factor 1, CHL2, chordin like 2, Chordin like protein 2 precursor, Chordin related protein 2, CRDL2_HUMAN.
Background: CHRDL2 is a novel chordin like protein that can act as a BMP antagonist. Amember of the chordin family of proteins, it contains a signal peptide andthree CR (cysteine-rich repeat) domains. When expressed as a recombinantprotein it is secreted and binds to activin A, but not to BMP-2, -4, -6. Differential expression has been detected in developing chondrocytes, myoblasts, osteoblasts, and osteoarthritic joints. Complex alternative splicing of CHRDL2 potentially results in distinct isoforms that differ at their C termini, in the expression of signal peptide, and in the content of CR domains. CHRDL2 was originally characterized as a novel protein exclusively expressed in breast, lung, and colon tumors.
- Gen-ID
- 25884
-